Instil Bio, Inc. (TIL): Depreciation & Amortization
$534.0K
Year ended 2025-12-31
$284.0K
Trailing 12 months to 2026-06-30
-55.3%
3-year compound annual growth
+15.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $534.0K | -85.2% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $3.61M | -24.1% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $4.76M | -20.6% | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | $5.99M | +117.6% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $2.75M | +975.0% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $256.0K | n/a | 2022-03-07, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | 2025-12-31 | $534.0K | -85.2% |
| Neumora Therapeutics, Inc. (NMRA) | 2025-12-31 | $208.0K | -67.0% |
| Compass Therapeutics, Inc. (CMPX) | 2025-12-31 | $276.0K | -53.1% |
| enGene Therapeutics Inc. (ENGN) | 2025-10-31 | $500.0K | +66.7% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | $2.90M | -29.3% |
| Solid Biosciences Inc. (SLDB) | 2025-12-31 | $1.64M | -33.4% |
| DBV Technologies S.A. (DBVT) | 2025-12-31 | $2.99M | +9.8% |
Compare TIL, NMRA, CMPX, ENGN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗